Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.59
-36.01 (-3.82%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
88
89
Next >
24 Dividend Growth Stocks to Buy and Hold in 2024
January 21, 2024
Dividends are good. Growing dividends are even better.
Via
The Motley Fool
Here's What Investors Should Expect From Eli Lilly Stock in 2024
January 20, 2024
More headlines on the horizon.
Via
The Motley Fool
Will Eli Lilly Be Worth More Than Meta Platforms by 2030?
January 20, 2024
It would be quite the accomplishment for the drugmaker.
Via
The Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
January 20, 2024
These big winners could keep the momentum going.
Via
The Motley Fool
S&P 500 Shatters Records: The Top-Performing Stocks In January 2024
January 19, 2024
2023 was a historical milestone for S&P 500 as it once again surpassed record highs, largely due to tech giants and artificial intelligence. Top gainers were NVIDIA, Meta Platforms, and AMD.
Via
Benzinga
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Why Eli Lilly Stock Tumbled on Thursday
January 18, 2024
Investors were a bit concerned about an industrywide move.
Via
The Motley Fool
Is Lilly Getting Silly?
January 18, 2024
An old-school drug company, Eli Lilly (LLY), has worked its way into the
Via
Talk Markets
Healthcare Giant Eli Lilly Under FDA Lens Again For Manufacturing Lapses
January 19, 2024
Eli Lilly faces FDA scrutiny with eight deficiencies at its Branchburg plant, raising concerns on Emgality's manufacturing.
Via
Benzinga
Exposures
Product Safety
Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering?
January 18, 2024
Pharmaceuticals prices are already up in 2024: Can inflation-beating hikes be justified?
Via
Benzinga
Balancing Act: The Ultimate Guide To Large-Cap Growth Stocks With Low Risk
January 17, 2024
Via
Benzinga
Eli Lilly's Blockbuster Diabetes Drug Mounjaro Set To Enter New Markets Amid Manufacturing Boost
January 17, 2024
Discover Eli Lilly's global expansion plans for weight-loss drug Mounjaro in new countries. CEO David Ricks hints at potential U.K. launch. Explore our strategic manufacturing capacity expansion.
Via
Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
January 16, 2024
Via
Benzinga
Eli Lilly's Options: A Look at What the Big Money is Thinking
January 10, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
Via
Benzinga
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
January 15, 2024
For different reasons, both Eli Lilly and UnitedHealth are doing well enough to enact substantial dividend raises.
Via
The Motley Fool
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
January 14, 2024
Good things come to those who wait.
Via
The Motley Fool
These 9 Stocks Are Running To Start 2024
January 14, 2024
The S&P 500 is up just 0.2% in 2024. These stocks are off to a strong start.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024
January 14, 2024
Novo Nordisk may dominate the weight management space, but pharma giant Eli Lilly is quickly gaining steam.
Via
The Motley Fool
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong
January 13, 2024
The rise of Ozempic and Wegovy helped Novo Nordisk stock surge over 50% last year.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in 2024
January 13, 2024
These stocks appear to be on a clear path to continued growth.
Via
The Motley Fool
Portfolio Protection: 7 Risky Stocks to Drop Right Now
January 12, 2024
Ahead of further or unforeseen challenges, if you own any of these seven risky stocks, now's the time to bail.
Via
InvestorPlace
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
January 12, 2024
A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the latest advancements in Alzheimer's detection.
Via
Benzinga
FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts
January 11, 2024
The FDA released an update on Thursday stating that its preliminary review did not find definitive evidence that the drugs cause suicidal thoughts or actions. However, the FDA investigation will...
Via
Benzinga
Exposures
Product Safety
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains.
Via
InvestorPlace
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
January 11, 2024
Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the
Via
Benzinga
Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?
January 11, 2024
Pfizer is certainly a company that will need to continue to battle headwinds moving forward, but is PFE stock worth a buy?
Via
InvestorPlace
Why Eli Lilly Stock Skyrocketed 59% in 2023
January 11, 2024
Lilly's pipeline success in 2023 allowed it to to claim the crown as the biggest drugmaker on the planet by market cap.
Via
The Motley Fool
Bring On The Competition In Obesity Drugs: Novo Nordisk CEO Optimistic About Prolonged Patient Adherence to Obesity Drug Wegovy
January 10, 2024
Lars Fruergaard Jorgensen, CEO of Novo Nordisk A/S (NYSE: NVO), shared insights during the JPMorgan Healthcare conference, highlighting Wegovy's efficacy for weight loss, indicating that patients are...
Via
Benzinga
Wall Street Doesn't Expect Eli Lilly Stock to Move Much Higher in 2024. Here's Why Analysts Could Be Wrong.
January 10, 2024
Lilly's sizzle might not fizzle in the new year.
Via
The Motley Fool
3 Simple Tricks That Every Investor Should Use (but Most Don't)
January 09, 2024
Having a few tricks up your sleeve can increase your returns over time.
Via
The Motley Fool
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
88
89
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.